company background image
600216 logo

Zhejiang Medicine SHSE:600216 Stock Report

Last Price

CN¥15.55

Market Cap

CN¥15.5b

7D

-8.9%

1Y

39.2%

Updated

15 Oct, 2024

Data

Company Financials +

Zhejiang Medicine Co., Ltd.

SHSE:600216 Stock Report

Market Cap: CN¥15.5b

600216 Stock Overview

Manufactures and sells life nutrition and pharmaceutical products in China.

600216 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Zhejiang Medicine Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Medicine
Historical stock prices
Current Share PriceCN¥15.55
52 Week HighCN¥19.04
52 Week LowCN¥7.97
Beta0.076
11 Month Change4.08%
3 Month Change34.63%
1 Year Change39.21%
33 Year Change-5.76%
5 Year Change38.35%
Change since IPO459.69%

Recent News & Updates

Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

Sep 14
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

Recent updates

Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

Sep 14
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You

Aug 06
What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You

Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15

Jul 05
Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15

The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet

Jun 21
The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet

Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem

May 02
Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem

Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet

Mar 29
Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet

Shareholder Returns

600216CN PharmaceuticalsCN Market
7D-8.9%-5.7%-4.5%
1Y39.2%-8.5%-2.6%

Return vs Industry: 600216 exceeded the CN Pharmaceuticals industry which returned -8.5% over the past year.

Return vs Market: 600216 exceeded the CN Market which returned -2.6% over the past year.

Price Volatility

Is 600216's price volatile compared to industry and market?
600216 volatility
600216 Average Weekly Movement8.1%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement7.4%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 600216 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600216's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19976,227Chun Lei Luwww.zmc.top

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.

Zhejiang Medicine Co., Ltd. Fundamentals Summary

How do Zhejiang Medicine's earnings and revenue compare to its market cap?
600216 fundamental statistics
Market capCN¥15.48b
Earnings (TTM)CN¥472.71m
Revenue (TTM)CN¥8.26b

31.6x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600216 income statement (TTM)
RevenueCN¥8.26b
Cost of RevenueCN¥5.67b
Gross ProfitCN¥2.59b
Other ExpensesCN¥2.12b
EarningsCN¥472.71m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 25, 2024

Earnings per share (EPS)0.49
Gross Margin31.34%
Net Profit Margin5.72%
Debt/Equity Ratio7.9%

How did 600216 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

30%

Payout Ratio